Clinical Trials Directory

Trials / Completed

CompletedNCT05750745

A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste for the Relief of Dentine Hypersensitivity in a Chinese Population

A 12-Week, Randomised, Controlled, Examiner-blind, Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste for the Relief of Dentine Hypersensitivity in a Chinese Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
416 (actual)
Sponsor
HALEON · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the efficacy of the 0.454 percentage (%) weight/weight (w/w) stannous fluoride (SnF2) toothpastes for the relief of dentine hypersensitivity (DH) in China.

Detailed description

This study will be a single center, randomized, controlled, examiner-blind, 3 treatment arm, parallel group design study, stratified by maximum baseline Schiff sensitivity score (of the 2 selected 'test teeth'), with a treatment period of 12 weeks, to investigate the clinical efficacy of a SnF2 toothpaste for the relief of DH in a Chinese population. The SnF2 test dentifrice will be compared to commercialized negative and positive control toothpastes.

Conditions

Interventions

TypeNameDescription
DRUGSensodyne Sensitivity & GumSensodyne Sensitivity \& Gum toothpaste is containing 0.454% w/w SnF2.
DRUGCrest Cavity Protection Fresh LimeCrest Cavity Protection Fresh Lime is containing 1150 parts per million (ppm) fluoride as Sodium fluoride (NaF).
DRUGSensodyne Repair and ProtectSensodyne Repair and Protect toothpaste is containing 5.0% w/w calcium sodium phosphosilicate (CSPS).

Timeline

Start date
2023-05-08
Primary completion
2023-09-19
Completion
2023-09-19
First posted
2023-03-02
Last updated
2024-11-20
Results posted
2024-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05750745. Inclusion in this directory is not an endorsement.